Timing around autoimmune flares Autoimmune diseases characteristically cycle between flares (active disease) and remission (quiescent disease)
While effective, this conventional method often faced constraints such as the difficulty of perfectly aligning hardware with a patients unique anatomy with off-the-shelf implants, and the physical toll of harvesting a patients own bone for graft in certain cases
Results can be seen in as little as 24-48 hours, depending on the severity of the injury
Significantly, phase I clinical trials on BPC-157 as a treatment for ulcerative colitis involved strictly oral administration [26, 27, 28]
Unfortunately, this effect vanished after time ranging from 6 h to 4 days
For use in neuromuscular disorders, anaemias and poor nutrition